Common Names: European mistletoe
Korean mistletoe lectin (VCA) enhances breast cancer cell apoptosis by influencing M1 and M2 macrophage polarization. Results suggest potential for VCA as an anti-cancer agent.
Adding VA to PD-1/PD-L1 inhibitors in NSCLC patients improves overall survival. 56% reduced risk of death compared to PD-1/PD-L1 alone, especially in PD-L1-positive tumors. Need more trials for confirmation.
Mistletoe, especially L., may have cardioprotective properties for treating CVD. Further research is needed to understand its mechanisms, interactions with drugs, and determine therapeutic doses for clinical use.
This paper suggests using mistletoe extract as a potential treatment for dogs with cancer. It contains compounds that can inhibit cancer cell growth and stimulate the immune system, improving well-being. Its low side effect profile makes it worth considering.
A 78-year-old woman with gallbladder cancer refused further chemotherapy after recurrence. She started Viscum album therapy, which decreased metastases and reduced CA19-9 levels. This therapy could be a bridge to palliative chemotherapy for patients unable to undergo standard treatment for recurrent gallbladder cancer.
This review explores how integrative oncology strategies can support immune checkpoint inhibitor treatment for adult solid tumors. It is important because it can inform decisions on integrating these strategies to enhance the effectiveness of ICI treatment.
Study investigated treatment patterns of breast cancer patients in Switzerland using complementary and alternative medicine. Understanding this can improve integrative oncology care in the country.
Different mistletoe extracts from hawthorn, lime trees, willow trees, and poplar trees significantly inhibited bladder cancer cell growth. The extracts also induced apoptosis and altered the expression of certain proteins involved in cell cycle regulation. Integrating mistletoe into treatment regimens could optimize bladder cancer therapy.
This study investigated the anticancer effects of a parasitic plant (VaM) on breast cancer cells. VaM inhibited cell growth, induced cell death, and suppressed cancer signaling pathways. Combining VaM with low-dose doxorubicin showed promising results in treating breast cancer.
This study found that including Moringa oleifera, Phyllanthus amarus, and Viscum album leaf meal in the diet of weaned female rabbits can reduce the negative effects of heat stress. These herbal inclusions improve antioxidant activity, lower lipid peroxidation, and suppress inflammation in rabbits.
This review discusses the various species of mistletoe and their antioxidant effects. While the European mistletoe is widely used in medical treatments, the potential of other mistletoe species is still unclear.
In a health technology assessment, researchers examined the "Patient and Social aspects" of mistletoe therapy in breast cancer patients in German-speaking countries. Many patients choose this therapy alongside conventional treatment to reduce side effects and enhance their quality of life. By evaluating the value for users, the study aims to understand the significance of complementary mistletoe therapy in breast cancer care.
European mistletoe has been traditionally used for central nervous system disorders, but little is known about its neuropharmacological activity. This study aims to investigate the effects of Viscum album L. on motor and anxiety-related behavior in mice. The study found that the extract of mistletoe had a significant calming effect on the mice, reducing anxiety and improving motor behaviors. This highlights the potential neuropharmacological activity of European mistletoe in treating CNS disorders.